Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00293-X/fulltext?dgcid=hubspot_email_conferencealerts_ers23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=273462826&_hsenc=p2ANqtz-8jIXC4k1ZiCDQJFeZgO3V_A2wkCncuOBWd4jLErqvWkQ5GOSEX2O0sWMSWjKWd5ted1h7SLGBw03oY1nutcoHE6eJJ0A&utm_content=273462826&utm_source=hs_email